AIA
THC icon

Affinity Investment Advisors’s Tenet Healthcare THC Stock Holding History

Affinity Investment Advisors’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,601
Closed -$215K – 158
2025
Q1 		$215K Buy
+1,601
New +$211K 0.18% 135
2024
Q1 		– Sell
-6,327
Closed -$478K – 183
2023
Q4 		$478K Sell
6,327
-3,340
-35% -$212K 0.33% 91
2023
Q3 		$637K Sell
9,667
-519
-5% -$38.8K 0.41% 89
2023
Q2 		$829K Sell
10,186
-2,524
-20% -$180K 0.48% 72
2023
Q1 		$755K Buy
12,710
+50
+0.4% +$2.78K 0.4% 100
2022
Q4 		$618K Sell
12,660
-2,339
-16% -$108K 0.28% 125
2022
Q3 		$774K Hold
14,999
– – 0.4% 88
2022
Q2 		$788K Buy
14,999
+1,940
+15% +$135K 0.38% 87
2022
Q1 		$1.12M Sell
13,059
-2,636
-17% -$217K 0.46% 65
2021
Q4 		$1.28M Sell
15,695
-2,203
-12% -$161K 0.51% 59
2021
Q3 		$1.19M Sell
17,898
-520
-3% -$36.9K 0.53% 57
2021
Q2 		$1.23M Sell
18,418
-5,524
-23% -$343K 0.56% 58
2021
Q1 		$1.25M Sell
23,942
-730
-3% -$36.9K 0.46% 62
2020
Q4 		$985K Sell
24,672
-4,256
-15% -$137K 0.4% 69
2020
Q3 		$709K Hold
28,928
– – 0.31% 80
2020
Q2 		$524K Sell
28,928
-133
-0.5% -$2.62K 0.25% 102
2020
Q1 		$418K Buy
29,061
+6,880
+31% +$197K 0.21% 94
2019
Q4 		$844K Buy
22,181
+3,620
+20% +$108K 0.31% 63
2019
Q3 		$411K Buy
18,561
+1,072
+6% +$22.8K 0.13% 100
2019
Q2 		$361K Buy
17,489
+3,272
+23% +$75.4K 0.1% 118
2019
Q1 		$410K Buy
+14,217
New +$351K 0.08% 101

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Affinity Investment Advisors's THC Position: Q2 2025 in Review

Affinity Investment Advisors sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 1,601 shares — an estimated $215K sold.

Affinity Investment Advisors first reported a position in THC in Q1 2019 and held it in 21 quarters. The position peaked at $1.28M in Q4 2021. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Affinity Investment Advisors reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
  • Affinity Investment Advisors sold 1,601 Tenet Healthcare shares in Q2 2025, an estimated $215K.
  • Affinity Investment Advisors first reported a position in Tenet Healthcare in Q1 2019 and held it in 21 quarters.
  • Affinity Investment Advisors's Tenet Healthcare position peaked at $1.28M in Q4 2021.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Affinity Investment Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.